International reference: 6 US FDA recalls for this ingredient

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia. (bacteria)

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria. (bacteria)

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria. (bacteria)

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia. (bacteria)

CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia. (bacteria)

Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria (bacteria)

US-market enforcement records (OpenFDA), shown for reference - not specific to this product in Tanzania.

Registered Tanzania · TMDA

Infectious Coryza Inactivated Vaccine

Infectious Coryza Bacteria (Haemophilus Paragallinarum Serotypes A, B & C) 1x108 CFU

TAN 23 V 0308 Emulsion for Injection 1 x 108.0 CFU /DOSE

What it does

This medicine contains bacteria that are used to help treat certain health conditions.

Commonly used for: infections caused by bacteria, gastrointestinal disorders, restoring gut health

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
TAN 23 V 0308
Registration date
2023-06-30
Expiry date
2028-06-29
Status
Registered/Compliant
Active ingredient
Infectious Coryza Bacteria (Haemophilus Paragallinarum Serotypes A, B & C) 1x108 CFU
Strength
1 x 108.0 CFU /DOSE
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Hester Biosciences
Country of origin
INDIA
Manufacturer location
1st Floor, Pushpak Complex, Panchavati Circle,, Motilal Hirabhai Road,, Off C.G. Road,, Ellisbridge, Ahmedabad, Gujarat 380006, India

Source: Tanzania Medicines and Medical Devices Authority · fetched 2026-03-11 23:38:48 · updated 2026-09-24 03:00:46

Disclaimer: This information is sourced from Tanzania Medicines and Medical Devices Authority (Tanzania). Always consult a qualified healthcare professional before using any medication.

About bacteria

This medicine contains bacteria that are used to help treat certain health conditions.

What it treats

  • infections caused by bacteria
  • gastrointestinal disorders
  • restoring gut health

How it works

It works by introducing good bacteria into the body, which helps to fight off bad bacteria and supports overall health.

Who it's for

This medicine is suitable for people who have infections or conditions related to gut health.

Cautions

  • • Consult a healthcare provider if you have a weakened immune system.
  • • Not recommended for those with certain serious health issues.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About cfu

CFU is a medication used to support various health conditions.

How it works

The specific mechanism of action for CFU is not detailed.

Who it's for

This medication may be suitable for individuals with certain health conditions as determined by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About coryza

Coryza is a term often used to describe symptoms of a cold, such as a runny nose, sneezing, and congestion. It is not a specific medication but rather refers to the condition itself.

What it treats

  • cold symptoms (coryza)

How it works

Coryza symptoms result from inflammation in the nasal passages due to infection or irritation.

Who it's for

This condition can affect anyone, but it is more common in children and during cold weather.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About infectious

This medicine is used to treat infections caused by bacteria, viruses, or other pathogens.

What it treats

  • infections
  • bacterial infections
  • viral infections

How it works

It helps the body fight off infections by targeting and killing harmful germs or preventing them from growing.

Who it's for

This medicine is for people with infectious diseases that need treatment.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: bacteria

Bacteria are unicellular microorganisms that can exist as independent organisms or as parasites. They are characterized by their simple cell structure, lack of a nucleus, and their ability to reproduce rapidly. Some bacteria are beneficial, playing crucial roles in processes such as digestion and nutrient cycling, while others can cause infections and diseases in humans, animals, and plants.

Indications

  • Bacterial infections
  • Pneumonia
  • Urinary tract infections
  • Skin infections
  • Sepsis
  • Meningitis

Dosage

Children: Dosage varies by specific antibiotic and infection type. Refer to the BNF for Children for appropriate dosing.

Adults: Dosage varies by specific antibiotic and infection type. Refer to the prescribing information for each antibiotic.

Mechanism of action

Bacteria can have various mechanisms of action depending on the species. Pathogenic bacteria often produce virulence factors that help them invade host tissues, evade the immune system, and acquire nutrients. Common mechanisms include the secretion of toxins, adhesion to host cells, and the formation of biofilms. Antibiotics target specific bacterial functions, such as cell wall synthesis or protein synthesis, which can inhibit bacterial growth or kill the bacteria.

Pharmacodynamics

The pharmacodynamics of antibiotics against bacteria involve the relationship between drug concentration and the resulting effect on bacterial growth and survival. This includes the minimum inhibitory concentration (MIC), which is the lowest concentration of an antibiotic that prevents visible growth of bacteria. Antibiotics can exhibit bactericidal effects, killing bacteria, or bacteriostatic effects, inhibiting their growth. The efficacy of antibiotics can be influenced by factors such as bacterial resistance mechanisms, the site of infection, and the host's immune response.

Pharmacokinetics

Pharmacokinetics of antibiotics refers to the absorption, distribution, metabolism, and excretion of the drugs used to treat bacterial infections. Factors such as the route of administration (oral, intravenous, intramuscular), bioavailability, volume of distribution, and half-life determine how effectively an antibiotic reaches the site of infection. Some antibiotics may require dose adjustments based on renal or hepatic function. The presence of protein binding can also affect the free concentration of the drug available for action against bacteria.

Pregnancy

Consult a healthcare professional for advice on the use of antibiotics during pregnancy, as some may pose risks to fetal development.

Breast-feeding

Consult a healthcare professional before using antibiotics while breastfeeding, as some may pass into breast milk and affect the infant.

Storage

Store in a cool, dry place away from direct sunlight. Ensure that medications are kept out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: coryza

Coryza, commonly referred to as the common cold, is an upper respiratory tract infection primarily caused by viruses, especially rhinoviruses. It is characterized by symptoms such as nasal congestion, runny nose, sneezing, sore throat, and sometimes cough. Coryza typically resolves within a week to ten days and is self-limiting. Management focuses on symptomatic relief, as there is no specific antiviral treatment for the common cold.

Indications

  • Common cold
  • Allergic rhinitis
  • Seasonal allergies

Dosage

Children: Refer to specific product guidelines for dosing.

Adults: Refer to specific product guidelines for dosing.

Mechanism of action

Coryza is caused by viral infections, primarily affecting the nasal mucosa. The viruses infect epithelial cells in the upper respiratory tract, leading to inflammation, increased mucous production, and other symptoms. The immune response to the infection contributes to symptoms.

Pharmacodynamics

The pharmacodynamics related to the treatment of coryza involves antihistamines and decongestants. Antihistamines block H1 receptors, reducing allergic symptoms and mucus secretion. Decongestants act on alpha-adrenergic receptors, causing vasoconstriction in nasal blood vessels, which decreases nasal swelling and congestion. Symptomatic relief is achieved through these mechanisms, allowing for improved airflow and comfort.

Pharmacokinetics

The pharmacokinetics of medications used to treat coryza vary depending on the specific drug. For instance, oral antihistamines are absorbed through the gastrointestinal tract, with peak plasma concentrations typically occurring within 1 to 3 hours. Metabolism usually occurs in the liver, and the elimination half-lives vary by specific agent. Decongestants are also administered orally or nasally, with systemic absorption leading to rapid effects within minutes. The duration of action can range from 4 to 12 hours depending on the formulation.

Adverse effects

  • Nasal irritation
  • Dryness of the nasal mucosa
  • Sneezing
  • Headache
  • Fatigue

Precautions

  • Use with caution in patients with hypertension
  • May exacerbate asthma symptoms
  • Monitor for increased heart rate in patients with pre-existing cardiac conditions

Pregnancy

Caution is advised during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before use, as safety during breastfeeding is not well established.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Oral tablets
  • Nasal sprays
  • Topical ointments

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: infectious

Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. They can lead to a wide range of clinical presentations, from mild illnesses to severe, life-threatening conditions. Management typically involves the use of antimicrobial agents that target the specific pathogen responsible for the infection.

Indications

  • Bacterial infections
  • Viral infections
  • Fungal infections
  • Parasitic infections
  • Sepsis
  • Pneumonia
  • Urinary tract infections
  • Skin and soft tissue infections

Dosage

Children: Refer to specific drug monographs for dosing information based on the type of infection and child's age and weight.

Adults: Refer to specific drug monographs for dosing information based on the type of infection and pathogen involved.

Mechanism of action

The mechanism of action of antimicrobial agents varies widely depending on the class of drug. For example, antibiotics may inhibit cell wall synthesis, protein synthesis, or nucleic acid synthesis in bacteria. Antivirals often target viral replication processes, while antifungal agents disrupt cell membrane integrity or inhibit essential metabolic pathways in fungi.

Pharmacodynamics

Pharmacodynamics of infectious disease treatments involves understanding the drug's effects on the pathogen, including the minimum inhibitory concentration (MIC) that inhibits bacterial growth, or the time and concentration needed to effectively reduce viral load. The efficacy of the antimicrobial therapy is influenced by factors such as the site of infection, the immune response of the host, and the susceptibility profile of the pathogen.

Pharmacokinetics

Pharmacokinetics of antimicrobial agents encompasses absorption, distribution, metabolism, and excretion. For instance, antibiotics may be well absorbed orally but have variable bioavailability. Distribution can be affected by tissue permeability and protein binding. Metabolism may occur in the liver, and excretion is primarily renal, influencing dosing in patients with renal impairment.

Pregnancy

Consult healthcare professional; safety varies by specific infectious agent and treatment.

Breast-feeding

Consult healthcare professional; safety varies by specific infectious agent and treatment.

Storage

Store in a cool, dry place, away from direct sunlight; specific storage may vary by formulation.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.